Research for elucidating the resistance mechanism to RET tyrosine kinase inhibitors in patients with non-small-cell lung cancer harboring with RET fusion gene
Not Applicable
Recruiting
- Conditions
- Advanced non-small-cell lung cancer harboring with RET fusion gene
- Registration Number
- JPRN-UMIN000021802
- Lead Sponsor
- Cancer Research Institute, Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Having previously received alectinib 2.Patients whom an investigator deems ineligible for participation in this study for some other reason.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To find out the resistance mechanism to RET-TKI alectinib in NSCLC harboring with RET fusion gene
- Secondary Outcome Measures
Name Time Method